Tretinoin and benzoyl peroxide
Twyneo is a prescription topical cream combining tretinoin (0.1%) and benzoyl peroxide (3%) to treat acne by reducing inflammation and killing bacteria. Approved under FDA NDA214902 by Mayne Pharma, it's available in a 30g pump bottle starting August 2025. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Twyneo is a prescription topical cream combining tretinoin (0.1%) and benzoyl peroxide (3%) to treat acne by reducing inflammation and killing bacteria. Approved under FDA NDA214902 by Mayne Pharma, it's available in a 30g pump bottle starting August 2025. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Tretinoin and benzoyl peroxide", "mediaType": "text/html", "description": " Access the FDA dataset for Tretinoin and benzoyl peroxide — ANDA 214902 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214902" } ] |
| identifier | ANDA214902 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "drug-manufacturers", "drug-safety", "medications", "pharmaceuticals" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Tretinoin and benzoyl peroxide |
